Together-Breast Cancer Support Platform

Официальное название

"Together": A Bilingual Online Platform Support Intervention Project for Korean Breast Cancer Survivors

Обзор

The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support? Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.

Подробное описание

This study evaluates the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors, as well as its potential impact on psychosocial outcomes.

A total of 24 participants will be enrolled, including 8 mentors (breast cancer survivors diagnosed at least two years prior who have completed active treatment or are on long-term maintenance therapy) and 16 mentees (patients currently undergoing treatment).

Participants will be recruited through community outreach using study flyers with a QR code that links to an online eligibility screener. Individuals who complete the screener will be contacted by the study coordinator to confirm eligibility and complete the informed consent process prior to enrollment.

Mentors and mentees will be matched based on information collected from the screener, including demographic and clinical characteristics such as age group and cancer stage at diagnosis. Each mentor may be matched with up to two mentees.

Mentors will complete a structured training program prior to participation. All participants will engage in peer-support interactions through an online platform over a 12-week period, with a minimum expectation of at least one bidirectional interaction per week.

Data will be collected using REDCap. Participants will complete surveys at baseline, mid-intervention (weeks 4-5), and post-intervention (weeks 12-13), with an optional follow-up survey at 6 months.

Outcome measures include engagement metrics, quality of life, psychological well-being (including anxiety and depression), and perceived social support.

Первичные конечные точки

• Feasibility of peer-support platform engagement [Срок оценки: Week 1 to Week 12]

Вторичные конечные точки (3)

• Change in quality of life (FACT-B score) [Срок оценки: Baseline to Week 12]
• Change in social/family well-being (FACT-B social/family subscale) [Срок оценки: Baseline to Week 12]
• Change in self-efficacy score [Срок оценки: Baseline to Week 12]

Критерии участия

Критерии включения

Mentors:

• Age ≥ 18 years
• Self-identify as Korean
• Able to read, write, and speak both Korean and English
• Diagnosed with breast cancer ≥ 2 years prior to enrollment
• Completed active treatment or currently on long-term maintenance therapy
• Access to a smartphone, computer, or similar device compatible with the study platform
• Willing to participate for at least 3 months
• Willing to complete required training and surveys

Mentees:

• Age ≥ 18 years
• Self-identify as Korean
• Able to read, write, and speak Korean
• Diagnosed with breast cancer
• Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy)
• Access to a smartphone, computer, or similar device compatible with the study platform
• Willing to participate for at least 3 months
• Willing to complete required surveys

Критерии исключения

• Individuals who do not meet the inclusion criteria
• Individuals unable to use the online platform or required technology
• Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)
• Mentees diagnosed with ductal carcinoma in situ (DCIS)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения

Когортное

Центры проведения

США · 1 центр

• Cedars Siani Cancer — Los Angeles

Идентификаторы

NCT: NCT07499089 · Study00003360

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗